Parkinson's Virtual Biotech

Parkinson's Virtual Biotech, like other biotech companies, uses cutting-edge biological and chemical research to develop new treatments. It adopts successful methods from the business world to deliver new treatments more quickly. Founded by Parkinson’s UK in 2017, Parkinson's Virtual Biotech is now an international initiative in collaboration with the Parkinson’s Foundation. We believe that by working together rather than competing, we will reach a cure faster. This innovative approach is making a difference. The next treatment is closer than ever before.